NCT07813013

Brief Summary

Colonoscopy is a test that lets doctors look inside the large bowel to find and remove growths called polyps, which can develop into bowel cancer. Before the test, people take a bowel preparation to empty the bowel. Even so, the right side of the bowel is often not clean enough, and polyps there can be missed. This study is testing whether giving an enema (a small amount of fluid passed into the bowel) during the colonoscopy makes the right side of the bowel cleaner. Participants having a routine colonoscopy at Westmead Hospital or Auburn Hospital will be assigned by chance to either receive the enema during the procedure or to have their colonoscopy in the usual way. Neither group takes any extra preparation at home. The researchers will compare how clean the right side of the bowel is in each group, using a standard scoring system, and will also look at how many polyps are found. The aim is to find out whether this simple step improves the quality of colonoscopy.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
320

participants targeted

Target at P75+ for not_applicable

Timeline
24mo left

Started Nov 2026

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 10, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2028

Last Updated

September 24, 2026

Status Verified

September 1, 2026

Enrollment Period

2 years

First QC Date

September 4, 2026

Last Update Submit

September 20, 2026

Conditions

Keywords

Right ColonEnemaBoston Bowel Preparation ScaleAdenoma Detection RateBowel PreparationColonosocpyColon Polyps

Outcome Measures

Primary Outcomes (1)

  • Final total Boston Bowel Preparation Scale (BBPS) score on blinded external image and video review

    Sum of the segmental BBPS scores for the right, transverse and left colon (range 0-9, higher scores indicate better cleansing), determined by external expert reviewers masked to allocation from de-identified images and video of the withdrawal phase.

    During colonoscopy withdrawal (single procedure)

Secondary Outcomes (16)

  • Segmental Boston Bowel Preparation Scale scores on blinded external image and video review

    During colonoscopy withdrawal (single procedure)

  • Proportion of participants achieving adequate bowel preparation

    During colonoscopy withdrawal (single procedure)

  • Adenoma detection rate

    From colonoscopy until histopathology results are available, up to 4 weeks

  • Proximal adenoma detection rate

    From colonoscopy until histopathology results are available, up to 4 weeks

  • Sessile serrated lesion detection rate, overall

    From colonoscopy until histopathology results are available, up to 4 weeks

  • +11 more secondary outcomes

Study Arms (2)

Intra-procedural right colon Fleet enema

EXPERIMENTAL

Immediately after confirmed caecal intubation and randomisation, with the colonoscope tip in the right colon, a Fleet sodium phosphate enema is instilled into the right colon through the colonoscope working channel. The right colon is then refilled to the hepatic flexure using the foot-pump water jet. The fluid is not suctioned; the right lower quadrant is agitated by manual percussion. The lumen is re-insufflated with CO2 and the scope returned to the caecum before withdrawal begins, allowing the instilled solution and mobilised faecal residue to be carried distally through the transverse and left colon.

Drug: Sodium phosphate enema

Water control

PLACEBO COMPARATOR

Colonoscopy lets doctors look inside the large bowel to find and remove growths called polyps. Before the test, people take a bowel preparation to empty the bowel, but the right side of the bowel is often still not clean enough, and polyps there can be missed. This study is testing whether a small enema given through the colonoscope into the right side of the bowel, during the procedure, makes the whole bowel cleaner. Once the camera reaches the far end of the bowel, participants are assigned by chance to receive either the enema or the same volume of water. Everything else about the procedure is the same in both groups, and no extra preparation is taken at home. The recordings of each procedure are reviewed by independent experts who do not know which group the participant was in, and who score how clean each part of the bowel was. The researchers will also compare how many polyps were found in each group.

Other: Water instillation

Interventions

A single Fleet sodium phosphate enema (monobasic sodium phosphate monohydrate 19 g and dibasic sodium phosphate heptahydrate 7 g in 118 mL of saline) is administered once, intra-procedurally, into the right colon through the colonoscope working channel after confirmed caecal intubation. The enema nozzle is aligned with the working channel for delivery. The volume instilled is recorded and is not counted towards intra-procedural water-jet lavage. No further doses are given.

Also known as: Fleet enema, Monobasic sodium phosphate monohydrate / dibasic sodium phosphate heptahydrate
Intra-procedural right colon Fleet enema

Immediately after confirmed caecal intubation and randomisation, with the colonoscope tip in the right colon, 100 mL of water is instilled into the right colon through the colonoscope working channel using a syringe. All subsequent steps are identical to the intervention arm: the right colon is refilled to the hepatic flexure using the foot-pump water jet, the fluid is not suctioned, the right lower quadrant is agitated by manual percussion, and the lumen is re-insufflated with CO2 before the scope is returned to the caecum for withdrawal.

Water control

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 85 years
  • Undergoing elective full colonoscopy for any indication
  • Successful caecal intubation achieved during the procedure, confirmed prior to randomisation
  • Able to provide written informed consent

You may not qualify if:

  • Emergency colonoscopy
  • Known inflammatory bowel disease with active colitis in the examined segment
  • Familial polyposis syndromes
  • Prior major right hemicolectomy or altered anatomy preventing standard right colon assessment
  • Known obstructing colorectal malignancy precluding safe progression or adequate examination
  • Pregnancy
  • Renal failure (eGFR less than 30 mL/min)
  • Previous sodium phosphate enema within the preceding 24 hours
  • Contraindication to sodium phosphate administration as determined by the treating endoscopist

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Auburn Hospital

Auburn, New South Wales, 2144, Australia

Location

Westmead Hospital

Westmead, New South Wales, 2145, Australia

Location

MeSH Terms

Conditions

Colonic PolypsColorectal Neoplasms

Interventions

sodium phosphate

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Michael J Bourke, MBBS,FRACP

    Westmead Hospita, Endoscopy Unit

    STUDY DIRECTOR
  • Nicholas G Burgess, MBChB, PhD, FRACP

    Westmead Hospita, Endoscopy Unit

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nicholas G Burgess, MBChB, PhD, FRACP

CONTACT

Mayan Eitan, M.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Endoscopists performing the procedure cannot be masked. The withdrawal phase of every colonoscopy is video-recorded, de-identified and edited to remove any indication of allocation before review. Segmental and total BBPS are scored by external expert reviewers who are masked to allocation and are not involved in performing the study procedures. Statistical analysis is performed masked to allocation.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Staff Specialist Gastroenterologist

Study Record Dates

First Submitted

September 4, 2026

First Posted

September 10, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

November 1, 2028

Study Completion (Estimated)

November 1, 2028

Last Updated

September 24, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the published results will be available, including baseline demographic and clinical characteristics, colonoscopy indication, treatment allocation, operator-recorded and blinded video-review BBPS scores for each colonic segment, lesion detection and histopathology outcomes, procedural metrics (procedure and withdrawal times, sedation, intra-procedural water volume) and adverse events. Procedure videos will not be shared, as they are deleted once blinded review is complete. The linkage file containing identifiers will not be shared.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 12 months after publication of the primary results and ending 5 years thereafter.
Access Criteria
De-identified individual participant data may be made available to investigators whose proposed use of the data has been approved by the Coordinating Principal Investigator, for analyses aimed at achieving the aims of an approved proposal. Requests should be directed to the Coordinating Principal Investigator. Data sharing is subject to WSLHD Human Research Ethics Committee approval and a data sharing agreement.

Locations